Company intelligence / Profile preview

Guanghua Wutong

Chengdu, Sichuan, China

Ownership: Private
Development stage: Other

Overview

Guanghua Wutong is an investment subsidiary that has initiated 13 investment funds with nearly 10 billion RMB assets under management, focused on healthcare, biomedicine, advanced medical care, big data, and AI. It is noted for building a robust investment network and ecosystem in China, particularly in Wenjiang, Chengdu, and has supported benchmark companies such as C Ray Therapeutics (radiopharmaceuticals).

Industry: Investors

Partnerships

C Ray Therapeutics (radiopharmaceuticals)

Beyond the preview

Go deeper on Guanghua Wutong.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanghua Wutong.

Explore the full profile